title: From Papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination.
authors.affiliation: Affiliation of authors: Division of Cancer Epidemiology and Genetics (MS), Division of Cancer Prevention (MES) and National Cancer Institute (MS, MES), Bethesda, MD.
authors.forename: Mahboobeh
authors.initials: M
authors.lastname: Safaeian
authors.forename: Mark E
authors.initials: ME
authors.lastname: Sherman
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D019941:Cyclin-Dependent Kinase Inhibitor p16; D055088:Early Detection of Cancer / Q000379:methods*; D005260:Female; D006801:Humans; D019394:Ki-67 Antigen / Q000032:analysis*; D009363:Neoplasm Proteins / Q000032:analysis*; D002583:Uterine Cervical Neoplasms / Q000737:chemistry* / Q000175:diagnosis*; D002578:Uterine Cervical Dysplasia / Q000737:chemistry* / Q000175:diagnosis*
chemical_list: D014408:Biomarkers, Tumor; C000614131:CDKN2A protein, human; D019941:Cyclin-Dependent Kinase Inhibitor p16; D019394:Ki-67 Antigen; D009363:Neoplasm Proteins